Details for New Drug Application (NDA): 212743
✉ Email this page to a colleague
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 212743
Tradename: | CHLORZOXAZONE |
Applicant: | Par Pharm Inc |
Ingredient: | chlorzoxazone |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 212743
Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for 212743
Suppliers and Packaging for NDA: 212743
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 212743 | ANDA | Par Pharmaceutical, Inc. | 0254-2005 | 0254-2005-01 | 100 TABLET in 1 BOTTLE (0254-2005-01) |
CHLORZOXAZONE | chlorzoxazone | TABLET;ORAL | 212743 | ANDA | Par Pharmaceutical, Inc. | 0254-2053 | 0254-2053-01 | 100 TABLET in 1 BOTTLE (0254-2053-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Nov 2, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 375MG | ||||
Approval Date: | Apr 29, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription